Beijing
Merck will construct its Asia research and development headquarters in Beijing. Located in the Wangjing science and technology park, the 505,904-sf facility will provide laboratory and office space for 600 employees. The building will accommodate drug discovery, translational research, clinical development, regulatory affairs, and external scientific research programs. The first phase of construction is expected to reach completion by 2014.
